Amkay Products (BOM:544169) Debt-to-EBITDA : N/A (As of Dec. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Amkay Products Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Amkay Products's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹38.5 Mil. Amkay Products's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹9.2 Mil. Amkay Products's annualized EBITDA for the quarter that ended in Dec. 2023 was ₹0.0 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Amkay Products's Debt-to-EBITDA or its related term are showing as below:

During the past 3 years, the highest Debt-to-EBITDA Ratio of Amkay Products was 1.47. The lowest was 0.30. And the median was 1.34.

BOM:544169's Debt-to-EBITDA is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 1.26
* Ranked among companies with meaningful Debt-to-EBITDA only.

Amkay Products Debt-to-EBITDA Historical Data

The historical data trend for Amkay Products's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amkay Products Debt-to-EBITDA Chart

Amkay Products Annual Data

Trend

Mar21

Mar22

Mar23

Debt-to-EBITDA

0.30

1.47

1.34

Amkay Products Quarterly Data
	Mar21	Mar22	Mar23	Dec23
Debt-to-EBITDA	N/A	N/A	N/A	N/A

Competitive Comparison of Amkay Products's Debt-to-EBITDA

For the Medical Instruments & Supplies subindustry, Amkay Products's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amkay Products's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Amkay Products's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Amkay Products's Debt-to-EBITDA falls into.

Amkay Products Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Amkay Products's Debt-to-EBITDA for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(13.5	+	33.499)	/	35.097
	=	1.34

Amkay Products's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(38.468	+	9.153)	/	0
	=	N/A

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.

Amkay Products (BOM:544169) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Amkay Products Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Amkay Products's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Amkay Products (BOM:544169) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Amkay Products Ltd (BOM:544169) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

Waliv Road, Bunglow No. 68, Rashmi Park, CHS Ltd, Dhumal Nagar, Vasai, Thane, Mumbai, MH, IND, 401208

Website

Amkay Products Ltd is a healthcare company. It manufacture, assemble & market a comprehensive portfolio of medical devices, disposables and other Healthcare Products like Face Mask, Alcohol Swabs, Lancet Needles, Nebulizer, Pulse Oximeter, surgeon cap etc. used by healthcare centers, hospitals/clinics, nursing homes etc. Additionally, engaged in branding and marketing of some of the products like Diapers, Plastic Gloves, Suction Machines etc.

Amkay Products (BOM:544169) Headlines

No Headlines